750 likes | 876 Views
The 1993 Diabetes Control and Complications Trial (DCCT) established that individuals with type 1 diabetes benefit significantly from improved metabolic control. The results indicated that those using intensive treatment methods achieved a mean HbA1c level of 7.2%, compared to conventional treatments. This finding has underscored the importance of external insulin pumps as a tool for achieving optimal glucose management, highlighting their role in reducing complications and enhancing quality of life for people living with diabetes.
E N D